MaxCyte's chart data is dated 2026-10-09. There is no active technical signal. There are 1 published signal records.
MaxCyte last closed at $1.01 (-0.98%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -3.0×. Its overall grade ranks 233 of 736 stocks in Healthcare.
About this company
MaxCyte last closed at $1.01 (-0.98%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 233/736
Valuation grade A-
Related stocks
- Thermo Fisher ScientificCompetitor
세포공학·세포처리 플랫폼 및 바이오 연구장비 분야의 대형 경쟁사
- LonzaCompetitor
세포·유전자치료용 공정개발 및 제조 서비스에서 경쟁하는 글로벌 CDMO
- SartoriusCompetitor
세포치료 제조·생명과학 공정 솔루션에서 경쟁하는 주요 장비·소모품 업체
About MaxCyte
- What technical signals does MaxCyte (MXCT) have?
- MaxCyte current technical signals: no active technical signal.
- Is MaxCyte a cup-and-handle pattern?
- No. MaxCyte has no valid Cup signal right now.
- What published figures are available for MaxCyte?
- Trailing 12 months PER: -3.0×. Latest quarter PBR: 0.68×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-10 dataset
Turn what you saw on this name into a strategy
Ask Q about MaxCyte, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.